Predicting Metabolic Dysfunction Associated Steatotic Liver Disease Risk Using Patient-Derived Induced Pluripotent Stem Cells
Yuanyuan Qin, Parth D. Chhetri, Elizabeth Theusch, Grace Lim, Sheila S. Teker, Yu-Lin Kuang, Shahrbanoo Keshavarz Azizi Raftar, Mohammad Hossein Mehraban, Antonio Munoz-Howell, Varun Saxena, Dounia Le Guillou, Aras N. Mattis, Jacquelyn J. Maher, Marisa Wong Medina
This paper develops an iPSC-based risk predictor for MASLD using lipid accumulation measurements and validates it across three cohorts with varying performance.
Stem Cells Translational Medicine · Nov 9, 2025Peer-reviewedCell Biology